Analysis of recombinant human erythropoietin in drug formulations by high-performance capillary electrophoresis

被引:50
作者
Bietlot, HP [1 ]
Girard, M [1 ]
机构
[1] HLTH CANADA, BUR DRUG RES, SIR FG BANTING RES CTR, OTTAWA, ON K1A 0L2, CANADA
关键词
pharmaceutical analysis; erythropoietin; proteins; recombinant proteins; albumin; glycoproteins;
D O I
10.1016/S0021-9673(96)00767-4
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A high-performance capillary electrophoresis (HPCE) method was developed for the analysis of recombinant human erythropoietin (rhEPO) in final drug preparations. All products examined were formulated with large amounts of human serum albumin (HSA) which is used as a protein excipient. Due to their similar physical characteristics in solution, rhEPO and HSA could not be resolved under HPCE conditions previously developed for the separation of bulk rhEPO. Addition of 1 mM nickel chloride to the electrophoretic buffer allowed complete separation of the two proteins as well as separation of rhEPO into several glycoform populations. The method was linear over the concentration range of 0.03-1.92 mg/ml, with limits of detection and of quantitation of 0.01 and 0.03 mg/ml, respectively. The precision of the method was evaluated from intra- and inter-day replicate injections of both rhEPO standard solution and formulation. Components of within- and between-batch variances were consistently below 5%, which constituted an acceptable level of variation. Products from two manufacturers were analyzed and showed little qualitative but appreciable quantitative lot-to-lot variations for rhEPO content when expressed in terms of units of biological activity. The method also revealed qualitative differences between the two products.
引用
收藏
页码:177 / 184
页数:8
相关论文
共 25 条
[1]  
Battersby R., 1992, PATHOPHYSIOLOGY PHAR, P15, DOI [10.1007/978-3-642-77074-6_2, DOI 10.1007/978-3-642-77074-6_2]
[2]   HIGH-PERFORMANCE CAPILLARY ELECTROPHORESIS OF PROTEINS USING SODIUM DODECYL SULFATE-POLY(ETHYLENE OXIDE) [J].
BENEDEK, K ;
THIEDE, S .
JOURNAL OF CHROMATOGRAPHY A, 1994, 676 (01) :209-217
[3]  
Creighton TE, 1993, PROTEINS STRUCTURES, P139
[4]   THE ROLE OF CARBOHYDRATE IN ERYTHROPOIETIN ACTION [J].
DORDAL, MS ;
WANG, FF ;
GOLDWASSER, E .
ENDOCRINOLOGY, 1985, 116 (06) :2293-2299
[5]  
EISUKE T, 1988, BIOCHEMISTRY-US, V27, P5646
[6]   STRUCTURAL REQUIREMENTS FOR ADDITION OF O-LINKED CARBOHYDRATE TO RECOMBINANT ERYTHROPOIETIN [J].
ELLIOTT, S ;
BARTLEY, T ;
DELORME, E ;
DERBY, P ;
HUNT, R ;
LORENZINI, T ;
PARKER, V ;
ROHDE, MF ;
STONEY, K .
BIOCHEMISTRY, 1994, 33 (37) :11237-11245
[7]  
ELRASSI Z, 1990, CHROMATOGRAPHIC SCI, V51, P179
[8]   ASSESSMENT OF CAPILLARY ELECTROPHORESIS IN PHARMACEUTICAL APPLICATIONS - ANALYSIS AND QUANTIFICATION OF A RECOMBINANT CYTOKINE IN AN INJECTABLE DOSAGE FORM [J].
GUZMAN, NA ;
ALI, H ;
MOSCHERA, J ;
IQBAL, K ;
MALICK, AW .
JOURNAL OF CHROMATOGRAPHY, 1991, 559 (1-2) :307-315
[9]   ERYTHROPOIETIN - STRUCTURE, CONTROL OF PRODUCTION, AND FUNCTION [J].
JELKMANN, W .
PHYSIOLOGICAL REVIEWS, 1992, 72 (02) :449-489
[10]   APPLICATION OF HIGH-PERFORMANCE CAPILLARY ELECTROPHORESIS TO THE ANALYSIS OF CONFORMATION AND INTERACTION OF METAL-BINDING PROTEINS [J].
KAJIWARA, H .
JOURNAL OF CHROMATOGRAPHY, 1991, 559 (1-2) :345-356